Optimizing Psychological Treatment for Pain After Breast Cancer
Unknown statusNot applicableNCT05444101
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The present study aims to optimize psychological treatment for pain after breast cancer by identifying active treatment components. Specifically, a factorial design will be used to evaluate the efficacy and change processes of three psychological treatment components, which have been shown to be efficacious in the treatment of pain after breast cancer.
Study details
- Official title
- Optimizing Psychological Treatment for Pain After Breast Cancer: A Factorial Design Study
- Conditions
- Interventions
- Behavioral: Mindful attention
- Behavioral: Decentering
- Behavioral: Values and committed action
- Sponsor
- University of Aarhus
- Collaborators
- Danish Council for Independent Research
- Start date
- 2022-09-01
- Primary completion
- 2023-10-01
- Sex
- Female
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Denmark
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of primary breast cancer stage I-III * Min. 6 months post primary treatment (i.e., surgery, chemotherapy, and/or radiotherapy). Endocrine treatment, e.g., Letrozol or Tamoxifen, and/or Zoledronic acid and/or Herceptin treatment is allowed during study participation * Pain corresponding to a pain score of \>= 3 on pain intensity and/or pain interference measured by 11-point Numeric Rating Scales (NRSs) * Sufficient ability to communicate in Danish * Sufficient ability to participate in an online-delivered intervention Exclusion Criteria: * Non-curable breast cancer (stage IV) * Breast cancer recurrence * Bilateral breast cancer * Other current cancer disease * Other primary pain condition (e.g., fibromyalgia) * Current severe psychiatric disorder (e.g., psychosis) hindering study participation * Insufficient ability to communicate in Danish * Insufficient ability to participate in an online-delivered intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05444101